CMS Gives Boston Scientific Another Chance To Gain Brain Stent Coverage
This article was originally published in The Gray Sheet
Executive Summary
CMS will reassess its national Medicare non-coverage policy on intracranial stenting and angioplasty, the agency announced Aug. 24